ICU Medical Q1 2023 Earnings Report
Key Takeaways
ICU Medical reported first quarter 2023 revenue of $568.6 million, a gross profit of $192.0 million, and a net loss of $(9.8) million, or $(0.41) per diluted share. Adjusted diluted earnings per share was $1.74, and adjusted EBITDA was $102.0 million.
First quarter revenue was $568.6 million, compared to $543.1 million in the same period last year.
GAAP gross profit for the first quarter was $192.0 million, compared to $168.8 million in the same period last year.
GAAP net loss was $(9.8) million, or $(0.41) per diluted share, compared to $(38.1) million, or $(1.61) per diluted share, for the same period last year.
Adjusted diluted earnings per share was $1.74, compared to $1.82 for the first quarter of 2022.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as ''will,'' ''expect,'' ''believe,'' ''could,'' ''would,'' ''estimate,'' ''continue,'' ''build,'' ''expand'' or the negative thereof or comparable terminology, and may include (without limitation) information regarding the Company's expectations, goals or intentions regarding the future.
Revenue & Expenses
Visualization of income flow from segment revenue to net income